Professional Overview

Sonja Learmonth is a seasoned healthcare executive currently serving as the Director, Global Market Access and Pricing, Neuroscience at AbbVie in Chicago, Illinois. Her key expertise areas include market access, pricing, reimbursement, and neuroscience, with a strong industry focus on pharmaceuticals and healthcare.

Experience Summary

Current Role

As the Director, Global Market Access and Pricing, Neuroscience, Sonja is responsible for developing and implementing global market access and pricing strategies for neuroscience products. Her key responsibilities include leading cross-functional teams, collaborating with external stakeholders, and driving business growth through effective pricing and reimbursement strategies. Under her leadership, the company has seen significant growth in market share and revenue.

Career Progression

Sonja's career progression is marked by notable roles at AbbVie, Allergan, and Merck. Prior to her current role, she served as the Director, Global Market Access, Pricing and Reimbursement, Toxin Lead at AbbVie, where she led the development of global market access strategies for toxin products. At Allergan, she held various roles, including Senior Manager, Pricing Reimbursement and Access, and Pricing, Reimbursement and Access Manager. Her earlier career at Merck included roles as Franchise Lead and Marketing Manager.

Areas of Expertise

Sonja's areas of expertise include market access, pricing, reimbursement, and neuroscience, with a strong focus on the pharmaceutical and healthcare industries. Her technical competencies include data analysis, strategic planning, and project management. As a seasoned leader, she possesses strong leadership and management capabilities, with a proven track record of driving business growth and leading cross-functional teams.

Professional Impact

Sonja has made significant contributions to the pharmaceutical and healthcare industries through her work on market access, pricing, and reimbursement strategies. Her notable projects and initiatives have driven business growth, improved patient access to healthcare products, and enhanced the overall quality of healthcare services. While specific metrics are not available, her contributions have been recognized through her career progression and leadership roles.

Conclusion

In conclusion, Sonja Learmonth is a highly accomplished healthcare executive with a strong track record of driving business growth, leading cross-functional teams, and developing effective market access and pricing strategies. Her current focus on neuroscience and global market access has positioned her as a key player in the pharmaceutical and healthcare industries. With her strong leadership and management capabilities, she is poised to continue making significant contributions to the industry and driving business success.